Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.

MLA

Monk JP, et al. “Efficacy of Peripheral Androgen Blockade in Prostate Cancer Patients with Biochemical Failure after Definitive Local Therapy: Results of Cancer and Leukemia Group B (CALGB) 9782.” Cancer (0008543X), vol. 118, no. 17, Sept. 2012, pp. 4139–47. EBSCOhost, https://doi.org/10.1002/cncr.26732.

APA

Monk JP, Halabi S, Picus J, Hussain A, Philips G, Kaplan E, Ahles T, Gu L, Vogelzang N, Kelly WK, Small EJ, Cancer and Leukemia Group B, Monk, J. P., Halabi, S., Picus, J., Hussain, A., Philips, G., Kaplan, E., Ahles, T., & Gu, L. (2012). Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782. Cancer (0008543X), 118(17), 4139–4147. https://doi.org/10.1002/cncr.26732

Chicago

Monk JP, Halabi S, Picus J, Hussain A, Philips G, Kaplan E, Ahles T, et al. 2012. “Efficacy of Peripheral Androgen Blockade in Prostate Cancer Patients with Biochemical Failure after Definitive Local Therapy: Results of Cancer and Leukemia Group B (CALGB) 9782.” Cancer (0008543X) 118 (17): 4139–47. doi:10.1002/cncr.26732.